← Back to Bills
HR 9900118th CongressFailed / ExpiredHouse

BioTech Innovation and National Security Continuation Act

Policy Area: Armed Forces and National Security
View on Congress.gov
Origin Chamber
House
Last Updated
Sep 9, 2025
Latest Action Date
Oct 1, 2024

Latest Action

Referred to the House Committee on Armed Services.

Official Summary

Official summary has not been imported yet.

GovScope Watchdog™

AI Government Intelligence™
Executive Summary

The BioTech Innovation and National Security Continuation Act (H.R. 9900) is a legislative proposal introduced in the 118th Congress aimed at advancing biotechnology innovation in the context of national security. The bill was referred to the House Committee on Armed Services but did not progress further and ultimately failed or expired. Specific details about the bill's provisions, funding, or implementation mechanisms are not available in the provided source data.

Bottom Line

H.R. 9900 sought to support biotechnology innovation related to national security but did not advance beyond committee referral and expired without enactment.

Policy Risk Level
🟡 Medium
Neutral Risk Assessment
Key Points
  • The bill focuses on biotechnology innovation within the scope of armed forces and national security.
  • It was introduced in the House of Representatives during the 118th Congress.
  • The latest recorded action was referral to the House Committee on Armed Services on October 1, 2024.
  • The bill ultimately failed or expired without further legislative action.
Who Benefits?

['Biotechnology industry stakeholders involved in national security applications', 'Department of Defense and related national security agencies', 'Research institutions focused on biotech innovation with defense relevance']

Potential Concerns

['Lack of publicly available full bill text limits assessment of implementation details and funding requirements.', 'Uncertainty about oversight mechanisms and authority granted by the bill due to missing text.', 'Potential challenges in balancing innovation promotion with national security safeguards.']

Political Context

The bill was introduced in the House during the 118th Congress and referred to the House Committee on Armed Services. It did not advance beyond committee referral and was classified as failed or expired as of the latest update in September 2025. The policy area aligns with ongoing congressional interest in biotechnology's role in national defense.

Hidden Impact Review

Hidden impact flags detected: 1

GovScope reviewed 1 policy-risk categories. Hover for a quick definition. Click detected flags for bill-specific details.

1 Detected
Detected Flags
Indirect Effects

['Potential stimulation of biotech research and development in defense sectors if enacted.', 'Possible influence on future legislative efforts to integrate biotechnology with national security strategies.', 'May affect funding priorities within the Department of Defense and related agencies.']

GovScope Watchdog Notes

The absence of the full bill text and official summary limits transparency and public understanding of the bill's specific provisions and implications. This gap underscores the importance of accessible legislative documentation for effective oversight and informed public discourse.

Passage Likelihood: LowConfidence: 70%Model: gpt-4.1-mini

GovScope Intelligence Roadmap

Future bill intelligence will connect sponsors, committee referrals, related votes, campaign finance, disclosures, and stock trades into one legislative intelligence view.

Enterprise Ready